zafirlukast
BACKGROUND: Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a       leukotriene receptor antagonist, are both indicated for the treatment of asthma       in adolescent and adult patients.
BACKGROUND: Salmeterol, a long-acting beta2 -agonist, and  @SUBJECT$  @PREDICAT$ , are both indicated for the treatment of  @OBJECT$        in adolescent and adult patients.